---
title: "B3GNT5"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene B3GNT5"
tags: ['GeneB3GNT5', 'Cancer', 'NeurodegenerativeDisorders', 'Glycosyltransferase', 'TherapeuticTargets', 'SNVs', 'Biomarkers', 'AlzheimersDisease']
---

# Information about Gene B3GNT5

## Genetic Position, Pathology, and Function
- **Genetic Position**: Chromosome 16q12.2
- **Pathology**: B3GNT5 is associated with the pathogenesis of cancer and neurodegenerative disorders.
- **Function**: B3GNT5 encodes for an enzyme that catalyzes the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine to a branched-chain poly-N-acetyllactosamine acceptor.

## External IDs and Aliases
- **Gene ID**: 84002
- **Genomic Location**: NC_000016.10 (36416857..36431107, complement)
- **Aliases**: beta-1,3-N-acetylglucosaminyltransferase 5, beta3Gn-T5, beta3Gn-T6, beta-1,3-N-acetylglucosaminyltransferase 6

## External Sites
- [HGNC]([Click](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:24653))
- [NCBI Entrez]([Click](https://www.ncbi.nlm.nih.gov/gene/84002))
- [Ensembl]([Click](https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000196367;r=16:36416857-36431107))
- [OMIM]([Click](https://omim.org/entry/612624))
- [UniProtKB/Swiss-Prot]([Click](https://www.uniprot.org/uniprot/Q9NSC7))

## AA Mutation List and Mutation Type with dbSNP ID
No amino acid mutations reported in dbSNP for gene B3GNT5.

## Somatic SNVs/InDels with dbSNP ID
- c.367A>G (p.Met123Val) with dbSNP ID rs778485096
- c.628A>T (p.Asn210Tyr) with dbSNP ID rs771169295

## Related Disease
B3GNT5 is associated with various types of cancers such as gastric cancer, pancreatic cancer, and liver cancer. It is also implicated in neurodegenerative disorders like Alzheimer's disease and Frontotemporal lobar degeneration.

## Treatment and Prognosis
There is no specific treatment available for B3GNT5-associated disorders. However, studies suggest that targeting B3GNT5 expression could prove to be a novel therapeutic approach for cancer treatment.

## Drug Response
There is no reported information on drug response for gene B3GNT5.

## Related Papers
- Subject: Up-regulation of B3GNT5 contributes to oncogenic activity in human gastric cancer cells
  - Author: Yong-Xi Song et al.
  - DOI: [10.1038/s41598-017-05683-3]([Click](https://doi.org/10.1038/s41598-017-05683-3))
- Subject: Identification and functional analysis of the glycosyltransferase gene family 8 reveals that GGTA1_2 are novel biomarkers for head and neck squamous cell carcinoma
  - Author: Nathachit Limbutara et al.
  - DOI: [10.1371/journal.pone.0198816]([Click](https://doi.org/10.1371/journal.pone.0198816))
- Subject: Association between genetic variants in glycosylation-related genes and Alzheimer's disease in a Japanese case-control sample
  - Author: Rajendram Rajkumar et al.
  - DOI: [10.1016/j.neurobiolaging.2012.09.018]([Click](https://doi.org/10.1016/j.neurobiolaging.2012.09.018))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**